Literature DB >> 32770107

PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.

Ayan Chanda1, Yoshiho Ikeuchi2,3, Kunal Karve1, Anusi Sarkar1, Amrita Singh Chandhoke1,4, Lili Deng1, Azad Bonni2, Shirin Bonni5.   

Abstract

SUMO E3 ligases specify protein substrates for SUMOylation. The SUMO E3 ligases PIAS1 and TIF1γ target the transcriptional regulator SnoN for SUMOylation leading to suppression of epithelial-mesenchymal transition (EMT). Whether and how TIF1γ and PIAS1 might coordinate SnoN SUMOylation and regulation of EMT remained unknown. Here, we reveal that SnoN associates simultaneously with both TIF1γ and PIAS1, leading to a trimeric protein complex. Hence, PIAS1 and TIF1γ collaborate to promote the SUMOylation of SnoN. Importantly, loss of function studies of PIAS1 and TIF1γ suggest that these E3 ligases act in an interdependent manner to suppress EMT of breast cell-derived tissue organoids. Collectively, our findings unveil a novel mechanism by which SUMO E3 ligases coordinate substrate SUMOylation with biological implications.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32770107      PMCID: PMC7853041          DOI: 10.1038/s41418-020-0599-8

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  43 in total

1.  Sumoylated SnoN represses transcription in a promoter-specific manner.

Authors:  Ying-Han R Hsu; Krishna P Sarker; Isabelle Pot; Angela Chan; Stuart J Netherton; Shirin Bonni
Journal:  J Biol Chem       Date:  2006-09-11       Impact factor: 5.157

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

Review 4.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

5.  High-throughput mapping of a dynamic signaling network in mammalian cells.

Authors:  Miriam Barrios-Rodiles; Kevin R Brown; Barish Ozdamar; Rohit Bose; Zhong Liu; Robert S Donovan; Fukiko Shinjo; Yongmei Liu; Joanna Dembowy; Ian W Taylor; Valbona Luga; Natasa Przulj; Mark Robinson; Harukazu Suzuki; Yoshihide Hayashizaki; Igor Jurisica; Jeffrey L Wrana
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

6.  TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.

Authors:  S Bonni; H R Wang; C G Causing; P Kavsak; S L Stroschein; K Luo; J L Wrana
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

7.  Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

Authors:  Ivo A Hendriks; David Lyon; Clifford Young; Lars J Jensen; Alfred C O Vertegaal; Michael L Nielsen
Journal:  Nat Struct Mol Biol       Date:  2017-01-23       Impact factor: 15.369

8.  p53 sumoylation: mechanistic insights from reconstitution studies.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Epigenetics       Date:  2009-10-09       Impact factor: 4.528

9.  TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.

Authors:  Yoshiho Ikeuchi; Shorafidinkhuja Dadakhujaev; Amrita S Chandhoke; Mai Anh Huynh; Anna Oldenborg; Mikako Ikeuchi; Lili Deng; Eric J Bennett; J Wade Harper; Azad Bonni; Shirin Bonni
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

10.  Identification of a Novel Link between the Protein Kinase NDR1 and TGFβ Signaling in Epithelial Cells.

Authors:  Isabelle Pot; Shachi Patel; Lili Deng; Amrita Singh Chandhoke; Chi Zhang; Azad Bonni; Shirin Bonni
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more
  4 in total

Review 1.  SUMOylation Wrestles With the Occurrence and Development of Breast Cancer.

Authors:  Yuanyuan Qin; Hong Yuan; Xu Chen; Xinyi Yang; Zhengcao Xing; Yajie Shen; Wanying Dong; Siming An; Yitao Qi; Hongmei Wu
Journal:  Front Oncol       Date:  2021-04-21       Impact factor: 6.244

Review 2.  The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.

Authors:  Xiaoxia Shi; Yixin Du; Shujing Li; Huijian Wu
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

Review 3.  Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.

Authors:  Nieves Lara-Ureña; Vahid Jafari; Mario García-Domínguez
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

4.  PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation.

Authors:  Farjana Saiada; Kun Zhang; Renfeng Li
Journal:  Cell Biosci       Date:  2021-07-08       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.